Production (Stage)
LENZ Therapeutics, Inc.
LENZ
$32.97
$1.013.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 193.98M | 209.03M | 217.11M | 196.11M | 213.28M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.77M | 2.77M | 3.48M | 3.12M | 3.28M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 114.00K | 114.00K | 114.00K | 114.00K | 114.00K |
| Total Current Assets | 197.86M | 211.92M | 220.70M | 199.35M | 216.67M |
|
|
|||||
| Total Current Assets | 197.86M | 211.92M | 220.70M | 199.35M | 216.67M |
| Net Property, Plant & Equipment | 2.00M | 1.99M | 1.91M | 1.89M | 627.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.40M | 1.40M | 1.40M | 1.40M | 21.00K |
| Total Assets | 201.25M | 215.30M | 224.01M | 202.64M | 217.32M |
|
|
|||||
| Total Accounts Payable | 3.66M | 4.26M | 2.76M | 4.41M | 7.13M |
| Total Accrued Expenses | 4.40M | 5.58M | 4.32M | 3.53M | 11.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 509.00K | 567.00K | 625.00K | 649.00K | 433.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.57M | 10.41M | 7.71M | 8.58M | 18.89M |
|
|
|||||
| Total Current Liabilities | 8.57M | 10.41M | 7.71M | 8.58M | 18.89M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 673.00K | 814.00K | 953.00K | 1.05M | 156.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 64.00K | 83.00K | 111.00K |
| Total Liabilities | 9.24M | 11.22M | 8.73M | 9.72M | 19.16M |
|
|
|||||
| Common Stock & APIC | 351.52M | 348.90M | 347.12M | 315.13M | 310.06M |
| Retained Earnings | -159.63M | -145.01M | -132.36M | -122.15M | -111.89M |
| Treasury Stock & Other | 123.00K | 196.00K | 523.00K | -62.00K | -1.00K |
| Total Common Equity | 192.01M | 204.08M | 215.28M | 192.92M | 198.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 192.01M | 204.08M | 215.28M | 192.92M | 198.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 192.01M | 204.08M | 215.28M | 192.92M | 198.17M |
|
|
|||||